Medifast declares $1.65 quarterly dividend payable Aug 8, 2023

The stockholders voted on a proposal to approve, on an advisory basis, a frequency of one-year of the advisory vote on executive compensation. The proposal was approved for an annual vote by a vote of the stockholders as follows: Once Every Year: 7,528,144 Once Every 2 Years: 36,611 Once Every 3 Years: 354,240 Abstained: 36,377 Broker Non-Votes: 1,059,865

The stockholders voted on a proposal to ratify the appointment of RSM US LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2023. The proposal was approved by a vote of stockholders as follows: For: 8,949,489 Against: 55,282 Abstained: 10,466

The stockholders voted on a proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers as set forth in the proxy statement for the Annual Meeting. The proposal was approved by a vote of the stockholders as follows: For: 7,495,497 Against: 372,673 Abstained: 87,201 Broker Non-Votes: 1,059,866

The number of shares voted and broker non-votes for the directors nominated for re-election to the Board are set forth below. Director Name For Against Abstained Broker Non-Votes Jeffrey J. Brown 7,690,887 234,232 30,252 1,059,866 Daniel R. Chard 7,656,983 278,797 19,591 1,059,866 Elizabeth A. Geary 7,849,710 77,812 27,849 1,059,866 Michael A. Hoer 7,846,691 81,211 27,469 1,059,866 Scott Schlackman 7,810,395 117,616 27,360 1,059,866 Andrea B. Thomas 7,387,316 532,634 35,421 1,059,866 Ming Xian 7,542,094 385,088 28,189 1,059,866